Life sciences companies will face a new set of challenges in a post-Covid-19 world. Whether you’re an investor in a life sciences company, a contract development and manufacturing organization, CSO (Chief Scientific Officer) or the CEO, you’ll have concerns about how the “new normal” will affect your business operations. For...
Read More
